Bristol-Myers Shells Out $21M To Settle Orencia Suit
Bristol-Myers Squibb Co. has agreed to pay $21 million to drug developer ZymoGenetics Inc. to settle a patent lawsuit over Bristol Myers' rheumatoid arthritis drug Orencia, both companies said in regulatory...To view the full article, register now.
Already a subscriber? Click here to view full article